Home
Conditions
Immunocompromised

Clinical trial condition

Immunocompromised

Explore clinical trials studying Immunocompromised. Study availability and eligibility vary by location and protocol.

10 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Immunocompromised trial results

Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

NCT06615635

Conditions: Alpha Radiation, Brachytherapy, Carcinoma, +13 more
Locations: Banner Health Gilbert, Arizona, United States

Us Dermatology Parthners Phoenix, Arizona, United States

Alliance Dermatology Phoenix, Arizona, United States

Integrity Research Clinical Associates Boca Raton, Florida, United States

View Trial Details

Recruiting

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

NCT03808922

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +14 more
Locations: City of Hope cancer Center Duarte, California, United States

University of California Davis Health System Sacramento, California, United States

Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

University of Iowa Health Care Iowa City, Iowa, United States

View all 28 locations

View Trial Details

Recruiting

Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

NCT03425526

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations

NCT07120464

Conditions: Chronic Disease, Disease Attributes, Immunocompromised, +3 more
Locations: Luohu District People's Hospital. Shenzhen, Guangdong, China

View Trial Details

Not Yet Recruiting

Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients

NCT07391046

Conditions: Asplenia, Autoimmune Diseases, Blood-Borne Infections, +38 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients

NCT06610643

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

NCT05020145

Conditions: Breakthrough Infection, Breakthrough Infections, COVID-19, +18 more
Locations: Pfizer Inc. New York, United States

View Trial Details

Completed

Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients

NCT03262584

Conditions: Agranulocytosis, Bacterial Infections and Mycoses, Body Temperature Changes, +15 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Seasonal Flu Vaccine in Adult Transplant Recipients

NCT01258023

Conditions: Immunocompromised, Transplanted
Locations: Medical School Hannover Hanover, Germany

View Trial Details

Active, Not Recruiting

Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

NCT03168815

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +10 more
Locations: Mount Sinai Hospital Toronto, Ontario, Canada

View Trial Details

Immunocompromised

Immunocompromised trial results

Related conditions